Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Neoplasms 1Prostatic Neoplasms 1Clear-cell metastatic renal cell carcinoma 1

Interventions

Magnetic Resonance Spectroscopy 11trametinib 8selpercatinib 7pembrolizumab 7dabrafenib 7Nivolumab 7Iodine-131 6lenvatinib 5Specimen Handling 5Biopsy 5cabozantinib 4Vemurafenib 4Iodine-124 4larotrectinib 3durvalumab 3binimetinib 3anlotinib 3Ipilimumab 3Immunoglobulin G 3Fluorodeoxyglucose F18 3Disulfides 3Cyclophosphamide 3Cetuximab 3vandetanib 2ulixertinib 2pralsetinib 2omipalisib 2defactinib 2copanlisib 2cemiplimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Neoplasms × Radiopharmaceuticals × 1 year × Clear all
NCT04892303 2025-07-01

Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Recruiting
48 enrolled
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡